Bispecific antibodies in cancer therapy.
Weiner
L M
LM
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
D018033:Antibodies, Bispecific / Q000276:immunology*; D000920:Antibody-Dependent Cell Cytotoxicity; D000951:Antigens, Neoplasm / Q000276:immunology; D002465:Cell Movement; D018734:Genes, erbB-2 / Q000276:immunology / Q000502:physiology; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy; D008264:Macrophages; D009369:Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000276:immunology
D018033:Antibodies, Bispecific; D000951:Antigens, Neoplasm; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II